Viroj Boonyaratanakornkit

6PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersMolecular targetsPharmaceutical delivery technologiesNanoscale characterisationCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 02, 2023
PRB inhibited cell proliferation through let-7b-E2F1 in breast cancer.

Teeranut Asavasupreechar, Ryoko Saito-Koyama, Yasuhiro Miki

|Mar 02, 2022
Cell-penetrating peptides containing the progesterone receptor polyproline domain inhibits EGF signaling and cell proliferation in lung cancer cells.

Panthita Kaewjanthong, Sarintip Sooksai, Hironobu Sasano

|Apr 13, 2021
Triple SILAC identified progestin-independent and dependent PRA and PRB interacting partners in breast cancer.

Prangwan Pateetin, Gyorgy Hutvagner, Sarah Bajan

|Jul 15, 2016
Assessment of Anti-TNF-α Activities in Keratinocytes Expressing Inducible TNF- α: A Novel Tool for Anti-TNF-α Drug Screening.

Sutthirat Udommethaporn, Tewin Tencomnao, Eileen M McGowan

|Apr 14, 2015
The role of ovarian sex steroids in metabolic homeostasis, obesity, and postmenopausal breast cancer: molecular mechanisms and therapeutic implications.

Viroj Boonyaratanakornkit, Prangwan Pateetin

Pageof 1

Frequent Collaborators

1 joint publications

Prangwan Pateetin

1 joint publications

Sarintip Sooksai

1 joint publications

Sarah Bajan

1 joint publications

Teeranut Asavasupreechar